Loading…

OraSure has received an $18 million product supply contract with an unnamed foreign country to support a nationwide hepatitis C testing and treatment program. Deliveries will occur over 12 months through late 2017, with an option to extend through 2018.
“The international marketplace is becoming an increasingly important opportunity for our business and particularly the OraQuick HCV test.”lvb.com
Summarized from public sources; check the original articles before acting on it.